GO:0033209

BP

tumor necrosis factor-mediated signaling pathway

A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

PSMD11, PSMD12, TNFRSF11B, TNFSF11, TNFRSF10C, PSMD3, FOXO3, JAK2, TNFRSF21, PSMD10, TNFSF13, TNF, KRT18, KRT8, NGFR, UBC, PSMC3, TNFRSF1B, PSMB1, TNFSF4, FAS, PSMA1, PSMA2, PSMA3, PSMA4, CD27, PSMB8, PSMB9, PSMB4, PSMB5, TNFRSF8, CD40LG, PSMC2, LTBR, PSMB10, PSMC4, PSMB3, PSMD7, PSME3, PSMC1, PSMC6, RPS27A, UBA52, ADAM17, PSMD2, BIRC3, RIPK1, PSME4, TRADD, EDARADD, TNFRSF25, TNFRSF12A, TNFRSF19, PYCARD, TNFSF13B, TNFRSF11A

GO:0033210

BP

leptin-mediated signaling pathway

A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body.

MT3, STAT3, LEP, LEPR, ADIPOR1

GO:0033211

BP

adiponectin-activated signaling pathway

A series of molecular signals initiated by the binding of adiponectin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

ACSL1, ADIPOQ, SLC27A1, ADIPOR2, ADIPOR1

GO:0033227

BP

dsRNA transport

The directed movement of dsRNA, double-stranded ribonucleic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

FLOT1, RFTN1, RFTN2

GO:0033233

BP

regulation of protein sumoylation

Any process that modulates the frequency, rate or extent of the addition of SUMO groups to a protein.

EGR1

GO:0033234

BP

negative regulation of protein sumoylation

Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of SUMO groups to a protein.

CAPN3, CTNNB1, GNL3L, HMG20B

GO:0033235

BP

positive regulation of protein sumoylation

Any process that activates or increases the frequency, rate or extent of the addition of SUMO groups to a protein.

ARNT, HDAC4, RASD2, GNL3, TOLLIP

GO:0033260

BP

nuclear DNA replication

The DNA-dependent DNA replication that occurs in the nucleus of eukaryotic organisms as part of the cell cycle.

SLBP, DONSON

GO:0033262

BP

regulation of nuclear cell cycle DNA replication

Any process that modulates the frequency, rate or extent of The DNA-dependent DNA replication that occurs in the nucleus of eukaryotic organisms as part of the cell cycle.

TIPIN, CDT1, DACH1

GO:0033273

BP

response to vitamin

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin stimulus.

PEMT

GO:0033274

BP

response to vitamin B2

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B2 stimulus.

MTHFR

GO:0033275

BP

actin-myosin filament sliding

The sliding movement of actin thin filaments and myosin thick filaments past each other.

ACTC1

GO:0033277

BP

abortive mitotic cell cycle

A cell cycle in which mitosis is begun and progresses normally through the end of anaphase, but not completed, resulting in a cell with increased ploidy.

PTPN11

GO:0033278

BP

cell proliferation in midbrain

The multiplication or reproduction of cells, resulting in the expansion of a cell population in the midbrain.

FZD6, WNT2

GO:0033280

BP

response to vitamin D

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.

CYP27B1, STC2, TGFB1, PTH, CD4, BGLAP, ALPL, SPP1, TYR, PTGS2, STC1, TRIM25, TPCN2, AQP3

GO:0033292

BP

T-tubule organization

A process that is carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of the T-tubule. A T-tubule is an invagination of the plasma membrane of a muscle cell that extends inward from the cell surface around each myofibril.

ATP2A2, ANK2

GO:0033299

BP

secretion of lysosomal enzymes

The controlled release of lysosomal enzymes by a cell.

GNPTAB, NAGPA, BLOC1S6

GO:0033301

BP

cell cycle comprising mitosis without cytokinesis

A mitotic cell cycle in which mitosis is completed but cytokinesis does not occur, resulting in a cell containing multiple nuclei each with a chromosomal complement of the original ploidy (usually 2N).

E2F8

GO:0033306

BP

phytol metabolic process

The chemical reactions and pathways involving phytol, (2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol.

ALDH3A2

GO:0033313

BP

meiotic cell cycle checkpoint

A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a meiotic cell cycle until conditions are suitable for the cell to proceed to the next stage.

NSUN2

GO:0033314

BP

mitotic DNA replication checkpoint

A cell cycle checkpoint that acts during a mitotic cell cycle and prevents the initiation of mitosis until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the genome.

NAE1, TOPBP1, SLF1

GO:0033320

BP

UDP-D-xylose biosynthetic process

The chemical reactions and pathways resulting in the formation of UDP-D-xylose, uridinediphosphoxylose, a substance composed of xylose in glycosidic linkage with uridine diphosphate.

UXS1

GO:0033327

BP

Leydig cell differentiation

The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a Leydig cell. A Leydig cell is a testosterone-secreting cell in the interstitial area, between the seminiferous tubules, in the testis.

DHH, AR, MGST1, NKX2-1, NR0B1, TMF1

GO:0033343

BP

positive regulation of collagen binding

Any process that activates or increases the frequency, rate or extent of collagen binding.

ITGA2

GO:0033344

BP

cholesterol efflux

The directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.

NPC1, ABCA1, APOA1, APOE, APOA2, APOC1, APOC3, APOB, SOAT1, NPC2, APOA5, SCARB1, ABCA5, ABCG8

GO:0033345

BP

asparagine catabolic process via L-aspartate

The chemical reactions and pathways resulting in the breakdown of glutamate, via the intermediate L-aspartate.

ASRGL1

GO:0033353

BP

S-adenosylmethionine cycle

A cyclic series of interconversions involving S-adenosylmethionine, S-adenosyl-L-homocysteine, L-cysteine, and L-methionine. Couples utilization of the methyl group of SAM with recycling of the homocysteinyl group and regeneration of methionine.

AHCYL1, AHCY

GO:0033363

BP

secretory granule organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a secretory granule. A secretory granule is a small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion.

SERPINE2, CREB1

GO:0033364

BP

mast cell secretory granule organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a secretory granule in a mast cell. A secretory granule is a small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion.

SRGN, LYST

GO:0033365

BP

protein localization to organelle

A process in which a protein is transported to, or maintained in, a location within an organelle.

AP3D1, ANK2, CROCC, BICD1, BBS2

GO:0033368

BP

protease localization to mast cell secretory granule

Any process in which a protease is transported to, or maintained in, a location within a secretory granule in a mast cell.

SRGN

GO:0033371

BP

T cell secretory granule organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a secretory granule in a T cell. A secretory granule is a small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion.

SRGN

GO:0033373

BP

maintenance of protease location in mast cell secretory granule

A process in which a protease is maintained in a secretory granule in a mast cell and prevented from moving elsewhere.

SRGN

GO:0033382

BP

maintenance of granzyme B location in T cell secretory granule

A process in which the protease granyme B is maintained in a secretory granule in a T cell and prevented from moving elsewhere.

SRGN

GO:0033384

BP

geranyl diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of geranyl diphosphate.

FDPS

GO:0033387

BP

putrescine biosynthetic process from ornithine

The chemical reactions and pathways resulting in the formation of putrescine, 1,4-diaminobutane by decarboxylation of ornithine.

AZIN1, ODC1

GO:0033388

BP

putrescine biosynthetic process from arginine

The chemical reactions and pathways resulting in the formation of putrescine, 1,4-diaminobutane, from other compounds, including arginine.

AGMAT

GO:0033484

BP

nitric oxide homeostasis

A homeostatic process involved in the maintenance of an internal steady state of nitric oxide within an organism or cell.

CAV1

GO:0033488

BP

cholesterol biosynthetic process via 24,25-dihydrolanosterol

The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, via the intermediate 24,25-dihydrolanosterol.

CYP51A1

GO:0033489

BP

cholesterol biosynthetic process via desmosterol

The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, via the intermediate desmosterol.

SC5D, EBP, DHCR24, DHCR7

GO:0033490

BP

cholesterol biosynthetic process via lathosterol

The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, via the intermediate lathosterol.

SC5D, EBP, DHCR24, DHCR7

GO:0033504

BP

floor plate development

The progression of the floor plate over time from its initial formation until its mature state.

COBL, STIL

GO:0033512

BP

L-lysine catabolic process to acetyl-CoA via saccharopine

The chemical reactions and pathways resulting in the breakdown of L-lysine into other compounds, including acetyl-CoA, via the intermediate saccharopine.

DLST, AASS

GO:0033514

BP

L-lysine catabolic process to acetyl-CoA via L-pipecolate

The chemical reactions and pathways resulting in the breakdown of L-lysine into other compounds, including acetyl-CoA, via the intermediate L-pipecolate.

PIPOX

GO:0033522

BP

histone H2A ubiquitination

The modification of histone H2A by addition of one or more ubiquitin groups.

RNF8, UBE2A, UBE2B

GO:0033523

BP

histone H2B ubiquitination

The modification of histone H2B by addition of ubiquitin groups.

RNF8, UBE2E1

GO:0033539

BP

fatty acid beta-oxidation using acyl-CoA dehydrogenase

A fatty acid beta-oxidation pathway in which the initial step of each oxidation cycle, which converts an acyl-CoA to a trans-2-enoyl-CoA, is catalyzed by acyl-CoA dehydrogenase; the electrons removed by oxidation pass through the respiratory chain to oxygen and leave H2O as the product. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).

ACOX3, ACADSB, ACADVL, ACOX1, ETFDH, ACOX2

GO:0033540

BP

fatty acid beta-oxidation using acyl-CoA oxidase

A fatty acid beta-oxidation pathway in which the initial step, which converts an acyl-CoA to a trans-2-enoyl-CoA, is catalyzed by acyl-CoA oxidase; the electrons removed by oxidation pass directly to oxygen and produce hydrogen peroxide, which is cleaved by peroxisomal catalases. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).

NUDT19, ACOT8, ACOX3, SCP2, CRAT, HSD17B4, ACOX1, ACOX2, CROT

GO:0033552

BP

response to vitamin B3

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B3 stimulus.

CCL2

GO:0033555

BP

multicellular organismal response to stress

Any process that results in a change in state or activity of a multicellular organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).

LGALS1, ADCYAP1R1, PTEN, PPP3CA, SEPN1

GO:0033564

BP

anterior/posterior axon guidance

The process in which the migration of an axon growth cone is directed to a specific target site along the anterior-posterior body axis in response to a combination of attractive and repulsive cues. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.

UNC5C, UNC5B

GO:0033566

BP

gamma-tubulin complex localization

Any process in which a gamma-tubulin complex is transported to, or maintained in, a specific location.

MZT1

GO:0033567

BP

DNA replication, Okazaki fragment processing

The DNA metabolic process, occurring during lagging strand synthesis, by which RNA primers are removed from Okazaki fragments, the resulting gaps filled by DNA polymerization, and the ends ligated to form a continuous strand.

DNA2

GO:0033572

BP

transferrin transport

The directed movement of transferrin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

ATP6V0E1, ATP6V1G1, ATP6V1G2, TFRC, TF, ATP6V1B2, ATP6V1C1, SLC11A2, ATP6V0D1, TCIRG1, RAB11B, ATP6V1F, ATP6V1C2, ATP6V0A1, ATP6V1H, TFR2, ATP6V1D

GO:0033574

BP

response to testosterone

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.

MSTN, GNRH1, BGLAP, EDN1, GPI, THBS1, CDK4, NME1, PLN, CAD, CALR, DUSP1, TSPO, SRD5A2, NASP, HSF1, MTAP, KCNJ11, BAD

GO:0033578

BP

protein glycosylation in Golgi

The addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid in any compartment of the Golgi apparatus.

LMF1, FUT8

GO:0033590

BP

response to cobalamin

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalamin (vitamin B12) stimulus.

EGFR, RELA

GO:0033591

BP

response to L-ascorbic acid

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-ascorbic acid (vitamin C) stimulus.

GSTP1, SPARC, ITGA2

GO:0033594

BP

response to hydroxyisoflavone

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyisoflavone stimulus.

EGFR, BGLAP

GO:0033598

BP

mammary gland epithelial cell proliferation

The multiplication or reproduction of mammary gland epithelial cells, resulting in the expansion of a cell population. Mammary gland epithelial cells make up the covering of surfaces of the mammary gland. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.

TNFSF11, CEBPB, MAPK1, ID2, BTRC

GO:0033599

BP

regulation of mammary gland epithelial cell proliferation

Any process that modulates the frequency, rate or extent of mammary gland epithelial cell proliferation.

GPX1, BAX, PYGO2

GO:0033600

BP

negative regulation of mammary gland epithelial cell proliferation

Any process that stops, prevents or reduces the rate or extent of mammary gland epithelial cell proliferation.

BRCA2, PHB2

GO:0033601

BP

positive regulation of mammary gland epithelial cell proliferation

Any process that activates or increases the rate or extent of mammary gland epithelial cell proliferation.

IQGAP3, KDM5B

GO:0033602

BP

negative regulation of dopamine secretion

Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of dopamine.

DRD2, CNR1, ABAT

GO:0033603

BP

positive regulation of dopamine secretion

Any process that activates or increases the frequency, rate or extent of the regulated release of dopamine.

CXCL12, NPY2R, PINK1

GO:0033615

BP

mitochondrial proton-transporting ATP synthase complex assembly

The aggregation, arrangement and bonding together of a proton-transporting ATP synthase in the mitochondrial inner membrane.

ATPAF1

GO:0033617

BP

mitochondrial respiratory chain complex IV assembly

The aggregation, arrangement and bonding together of a set of components to form respiratory chain complex IV (also known as cytochrome c oxidase) in the mitochondrial inner membrane.

PET100, COX17, COX19, COX20, COX14, TIMM21, COA4, BCS1L, COA3

GO:0033619

BP

membrane protein proteolysis

The proteolytic cleavage of a transmembrane protein leading to the release of its intracellular or ecto-domains.

CTSH, TMPRSS6, SPPL3, SPPL2A, HM13

GO:0033622

BP

integrin activation

The aggregation, arrangement and bonding together of an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits, that lead to the increased affinity of the integrin for its extracellular ligands.

ITGB1BP1, FN1, COL16A1

GO:0033623

BP

regulation of integrin activation

Any process that modulates the frequency, rate, or extent of integrin activation.

FARP2, FBLIM1

GO:0033624

BP

negative regulation of integrin activation

Any process that stops, prevents, or reduces the frequency, rate, or extent of integrin activation.

PTGER4, KIF14

GO:0033625

BP

positive regulation of integrin activation

Any process that activates or increases the frequency, rate, or extent of integrin activation.

PIEZO1

GO:0033626

BP

positive regulation of integrin activation by cell surface receptor linked signal transduction

Any series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell that lead to the increased affinity of an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits, for its extracellular ligands.

CDH17

GO:0033627

BP

cell adhesion mediated by integrin

The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.

VTN, ITGB3, ICAM1, ITGB1, ITGAV, ITGA5, ITGA2, ITGA6, FBN1, ADAM17, COL16A1, ADAM9, ITGA11

GO:0033628

BP

regulation of cell adhesion mediated by integrin

Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.

ITGB1BP1, LPXN, PLAU, LYN, EFNA1, PIK3CG, PTK2, PTPN11

GO:0033629

BP

negative regulation of cell adhesion mediated by integrin

Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.

SNAI2, SERPINE1, MUC1, PTPN11, PDE3B, CYP1B1

GO:0033630

BP

positive regulation of cell adhesion mediated by integrin

Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.

SYK, RAC3, TGFB2, ADAM9, IFT74, CIB1

GO:0033631

BP

cell-cell adhesion mediated by integrin

The attachment of one cell to another cell via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.

ITGB1, ITGA5, ADAM9

GO:0033632

BP

regulation of cell-cell adhesion mediated by integrin

Any process that modulates the frequency, rate, or extent of cell-cell adhesion mediated by integrin.

ADA, DPP4

GO:0033634

BP

positive regulation of cell-cell adhesion mediated by integrin

Any process that activates or increases the frequency, rate, or extent of cell-cell adhesion mediated by integrin.

CCL5, PIEZO1

GO:0033668

BP

negative regulation by symbiont of host apoptotic process

Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of programmed cell death in the host, where programmed cell death proceeds by apoptosis. The host is defined as the larger of the organisms involved in a symbiotic interaction.

SERPINB9

GO:0033673

BP

negative regulation of kinase activity

Any process that stops, prevents, or reduces the frequency, rate or extent of kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.

MSTN, CSK, CDKN1B, CDKN1C, AJUBA, IRS2

GO:0033674

BP

positive regulation of kinase activity

Any process that activates or increases the frequency, rate or extent of kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.

NBN, MRE11A, LMO4, DSTYK, PIFO, GCN1, RAD50

GO:0033683

BP

nucleotide-excision repair, DNA incision

A process that results in the endonucleolytic cleavage of the damaged strand of DNA. The incision occurs at the junction of single-stranded DNA and double-stranded DNA that is formed when the DNA duplex is unwound.

ERCC1, PARP1, UBC, PCNA, ERCC2, XPA, POLD1, GTF2H1, RPA3, RFC4, RFC2, RFC5, RFC3, RBX1, RPS27A, UBA52, CUL4A, CUL4B, GTF2H2, POLD3, CHD1L, GTF2H4, ERCC4, POLD4, POLK, FAN1

GO:0033686

BP

positive regulation of luteinizing hormone secretion

Any process that activates or increases the frequency, rate or extent of the regulated release of luteinizing hormone.

LEP, FOXL2, SMAD4, KISS1

GO:0033687

BP

osteoblast proliferation

The multiplication or reproduction of osteoblasts, resulting in the expansion of an osteoblast cell population. An osteoblast is a bone-forming cell which secretes an extracellular matrix. Hydroxyapatite crystals are then deposited into the matrix to form bone.

JUNB

GO:0033688

BP

regulation of osteoblast proliferation

Any process that modulates the frequency, rate or extent of osteoblast proliferation.

NPR3, FGFR2, RHOA

GO:0033689

BP

negative regulation of osteoblast proliferation

Any process that stops, prevents or reduces the rate or extent of osteoblast proliferation.

GREM1, BCL2, SMAD3, SFRP1

GO:0033690

BP

positive regulation of osteoblast proliferation

Any process that activates or increases the rate or extent of osteoblast proliferation.

CYR61, LRP5, ITGAV, BMP2, SOX8, CTHRC1, HPSE

GO:0033692

BP

cellular polysaccharide biosynthetic process

The chemical reactions and pathways resulting in the formation of polysaccharides, polymers of many (typically more than 10) monosaccharide residues linked glycosidically, occurring at the level of an individual cell.

EXT1, EXT2

GO:0033693

BP

neurofilament bundle assembly

The assembly of neurofilaments into bundles, in which the filaments are longitudinally oriented, with numerous crossbridges between them. Neurofilament bundles may be cross-linked to each other, to membrane-bounded organelles or other cytoskeletal structures such as microtubules.

NEFH

GO:0033700

BP

phospholipid efflux

The directed movement of a phospholipid out of a cell or organelle.

ABCA1, APOA1, APOE, APOA2, APOC1, APOC3, APOA5

GO:0033762

BP

response to glucagon

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.

CYC1, QDPR, PFKFB1, CREB1, CCNA2, SREBF1, CRY1, CDO1

GO:0033861

BP

negative regulation of NAD(P)H oxidase activity

Any process that stops or reduces the activity of the enzyme NAD(P)H oxidase.

INS

GO:0033864

BP

positive regulation of NAD(P)H oxidase activity

Any process that activates or increases the activity of the enzyme NAD(P)H oxidase.

AGT, AGTR1, RFK

GO:0033962

BP

cytoplasmic mRNA processing body assembly

The aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body.

LSM3, DYNC1H1, LSM14A, EDC3, LIMD1, CNOT7, NOCT, LSM4

GO:0033993

BP

response to lipid

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus.

VPS4B, CD36, PPARG, HRSP12

GO:0034047

BP

regulation of protein phosphatase type 2A activity

Any process that modulates the activity of the enzyme protein phosphatase type 2A.

ENSA, PPP2R1A, PPP2R1B, HTT, ARPP19, IGBP1, SET, PPP2R3A, PPP2R5C, PPP2R5D, PPP2R5A, PPP2R5B, PPP2R4, ANKLE2, PPME1

GO:0034048

BP

negative regulation of protein phosphatase type 2A activity

Any process that stops or reduces the activity of the enzyme protein phosphatase type 2A.

MASTL

GO:0034058

BP

endosomal vesicle fusion

The homotypic fusion of endocytic vesicles to form or add to an early endosome.

VPS8, ANKFY1